Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
of the impaired membrane/endocytic trafficking in other neurological disorders such as Alzheimer’s Disease, Down syndrome and epilepsy. For more information of our lab, please visit https
-
MRC DiMeN Doctoral Training Partnership: A new imaging approach to unravel the mysteries of extracellular vesicle journey through tissues as a vector for cancer proliferation MRC DiMeN Doctoral
-
equivalencies: https://hr.uky.edu/employment/working-uk/equivalencies Required Related Experience No experience required. Required License/Registration/Certification KY Radiation Operator’s License at time of
-
information about equivalencies: https://hr.uky.edu/employment/working-uk/equivalencies Required Related Experience No experience required. Required License/Registration/Certification KY Radiation Operator’s
-
activation, cytotoxicity, and persistence. Additional methods may involve CRISPR-based perturbations, viral vector engineering, and immune cell manufacturing workflows relevant to CAR-based therapies. In vivo
-
of liquid chromatography systems (FPLC), development and optimization of chromatographic methodologies for the purification of nucleic acids and delivery vectors, as well as experience working in GMP-like
-
Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S) | Portugal | about 1 month ago
neurophysiology and electrophysiology methods, because we want to take advantage of the population selectivity that optical methods allow: we will use viral vectors with gene promoters that target a specific
-
announcing the search for applications for a tenure track faculty to join and expand its team. Qualified candidates will have a background in vector and transgene design and development for cellular therapy
-
of antiparasitic drugs and emergence of resistance. Biology and ecology of infectious disease vectors and their interactions with pathogens. Start of studies in the summer semester (April) Opening of applications
-
-responsive crosslinking, and incorporating active targeting vectors such as peptides, enabling controlled release and selective delivery in therapeutic contexts. This interdisciplinary project offers a unique